目的 探索妇科恶性肿瘤患者存在痛苦的潜在剖面及影响因素,并分析不同潜在剖面与希望水平的关系。方法 采用便利抽样法选取2024年1月至2024年12月在南通市肿瘤医院治疗的224例妇科恶性肿瘤患者作为调查对象,对其进行存在痛苦量表和希望水平量表的评估。潜在剖面分析、影响因素分析及方差分析用于统计检验。结果 224例妇科恶性肿瘤患者存在痛苦得分(26.12±5.33)分、希望水平得分为(29.56±4.13)分。妇科恶性肿瘤患者的存在痛苦可分为3个潜在剖面:高存在痛苦组、中存在痛苦组及低存在痛苦组。每个类别的妇科恶性肿瘤患者归属于各个潜在剖面的平均归属概率在97.5%~98.4%。3个类别组在年龄(χ2=11.816,P=0.019、肿瘤分期(χ2=9.853,P=0.043)、病程时长(χ2=21.815,P＜0.001)及自评社会支持(χ2=13.528,P=0.019)方面具有显著差异。多因素Logistic回归分析显示:年龄、肿瘤分期、病程时长及自评社会支持成为存在痛苦的影响因素(P＜0.05)。高存在痛苦组患者的希望水平显著低于中、低存在痛苦组(P＜0.01),中存在痛苦组患者的希望水平显著低于低存在痛苦组(P＜0.01)。结论 妇科恶性肿瘤患者存在痛苦分为高存在痛苦组、中存在痛苦组及低存在痛苦组3个亚组。临床工作人员应辨别不同类别患者的特征,针对高存在痛苦组的高危人群积极采用应对措施,尽可能降低其无助感及绝望感水平、提高患者的希望水平,对改善其治疗依从性、改善预后有重要意义。
Abstract
Objective To explore the potential profiles and influencing factors of existential distress in patients with gynecological malignant tumors, and to analyze the relationship between different potential profiles and the level of hope. Method By using the convenience sampling method, patients with gynecological malignant tumors who were treated in our hospital from January 2024 to December 2024 were selected as the survey subjects, and relevant scales were measured for them. Potential profile analysis, influencing factor analysis and analysis of variance were used for statistical tests. Result It showed that among 224 patients with gynecological malignant tumors, the pain score was (26.12±5.33) points and the hope level score was (29.56±4.13) points. The existential pain of patients with gynecological malignant tumors can be divided into three potential profiles: the high existential pain group, the medium existential pain group and the low existential pain group. The average attribution probability of each category of gynecological malignant tumor patients belonging to each potential profile ranges from 97.5% to 98.4%. There were significant differences among the three category groups in terms of age (χ2=11.816, P=0.019), tumor stage (χ2=9.853, P=0.043), disease duration (χ2=21.815, P<0.001), and self-assessed social support (χ2=13.528, P=0.019). Logistic regression analysis showed that age, tumor stage, disease duration and self-rated social support became the influencing factors for the existence of pain (P<0.05). The hope level of patients in the high presence of pain group was significantly lower than that in the medium presence of pain group (P<0.01) and significantly lower than that in the low presence of pain group (P<0.01). The hope level of patients in the medium presence of pain group was significantly lower than that in the low presence of pain group (P<0.01). Conclusion The existential distress of patients with gynecological malignant tumors is divided into three subgroups: the high existential distress group, the medium existential distress group and the low existential distress group. Clinical staff should identify the characteristics of different types of patients, actively adopt coping measures for the high-risk population in the high existential distress group, minimize their levels of helplessness and despair as much as possible, and increase the patients' hope level. This is of great significance for improving their treatment compliance and prognosis.
关键词
妇科恶性肿瘤 /
存在痛苦 /
潜在剖面分析 /
影响因素 /
希望水平 /
相关性
Key words
Gynecological malignant tumors /
Existential distress /
Potential profile /
Influencing factors /
Hope level /
Correlation
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] XIA C, DONG X, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022,135(5):584-590.
[2] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249.
[3] BUSKWOFIE A, DAVID-WEST G, CLARE C A. A review of cervical cancer: incidence and disparities[J]. J Natl Med Assoc, 2020,112(2):229-232.
[4] THRASTARDOTTIR T O, COPELAND V J, CONSTANTINOU C. The association between nutrition, obesity, inflammation, and endometrial cancer: a scoping review[J]. Curr Nutr Rep, 2023,12(1):98-121.
[5] CAO A, CARTMEL B, LI F Y, et al. Effect of exercise on chemotherapy-induced peripheral neuropathy among patients treated for ovarian cancer: a secondary analysis of a randomized clinical trial[J]. JAMA Netw Open, 2023,6(8):e2326463.
[6] VEHLING S, KISSANE D W. Existential distress in cancer: Alleviating suffering from fundamental loss and change[J]. Psychooncology, 2018,27(11):2525-2530.
[7] 袁泉, 刘梦婉, 陈凯琪, 等. 癌症患者存在痛苦的研究进展[J]. 护理学杂志, 2024,39(14):117-121.
[8] SCHIPPER S, NIGAM K, SCHMID Y, et al. Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases[J]. Cochrane Database Syst Rev, 2024,9(9):CD15383.
[9] VEHLING S, TIAN Y, MALFITANO C, et al. Attachment security and existential distress among patients with advanced cancer[J]. J Psychosom Res, 2019,116:93-99.
[10] FELDMAN D B, CORN B W. Hope and cancer[J]. Curr Opin Psychol, 2023,49:101506.
[11] WEI D, WANG L, LIU Y, et al. CAR-macrophage cell therapy: a new era of hope for pancreatic cancer[J]. Clin Cancer Res, 2025,31(19):4018-4031.
[12] JACOBS F, AGOSTINETTO E, MIGGIANO C, et al. Hope and hype around immunotherapy in triple-negative breast cancer[J]. Cancers, 2023,15(11):2933.
[13] 韩超, 孔为民. 2021年《国际妇产科联盟(FIGO)妇科恶性肿瘤指南》联合《美国国立综合癌症网络(NCCN)指南》解读卵巢癌、输卵管癌及原发性腹膜癌的诊治进展[J]. 中国临床医生杂志, 2022,50(3):270-274.
[14] 倪平, 陈京立, 刘娜. 护理研究中量性研究的样本量估计[J]. 中华护理杂志, 2010,45(4):378-380.
[15] 张帆, 朱树贞, 邓平基. 领悟社会支持量表在国内住院病人社会支持研究中的应用评价[J]. 护理研究, 2018,32(13):2048-2052.
[16] LO C, PANDAY T, ZEPPIERI J, et al. Preliminary psychometrics of the Existential Distress Scale in patients with advanced cancer[J]. Eur J Cancer Care (Engl), 2017,26(6):10.
[17] 肖惠敏, 林晓丹, 吴红, 等. 晚期癌症患者生存痛苦量表的汉化及信效度检验[J]. 护理学杂志, 2022,37(9):74-77.
[18] 赵海平, 王健. 血液透析患者的社会支持和希望[J]. 中华护理杂志, 2000,35(5):306-308.
[19] 袁小茜, 魏兴玲. 多发性骨髓瘤化疗病人癌因性疲乏与社会支持及希望水平的相关性分析[J]. 蚌埠医学院学报, 2023,48(10):1445-1450.
[20] PHILIPP R, KALENDER A, HARTER M, et al. Existential distress in patients with advanced cancer and their caregivers: study protocol of a longitudinal cohort study[J]. BMJ Open, 2021,11(4):e46351.
[21] ANDERSON L E, IRELAND M J, MYERS L, et al. Psychological distress and bowel cancer screening participation[J]. Psychooncology, 2023,32(2):229-236.
[22] O'DWYER M C. Care of cancer survivors: distress and mental health[J]. FP Essent, 2023,529:7-13.
[23] CARR A L, ROBERTS S, BONNEll L N, et al. Existential distress and meaning making among female breast cancer patients with cancer-related fertility concerns[J]. Palliat Support Care, 2023,21(2):196-204.
[24] LIN X, XU G, CHEN G, et al. Self-perceived burden predicts lower quality of life in advanced cancer patients: the mediating role of existential distress and anxiety[J]. BMC Geriatr, 2022,22(1):803.
[25] PATCHETT-MARBLE R, O'SULLIVAN S, TADWALKAR S, et al. Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer[J]. Can Fam Physician, 2022,68(11):823-827.
[26] REISER E, BÖTTCHER B, OSSIG C, et al. Female cancer survivors: sexual function, psychological distress, and remaining fertility[J]. J Assist Reprod Genet, 2024,41(4):1057-1065.
[27] SHARMA A, SRIYUKTASUTH A, PHLIGBUA W, et al. Psychological distress among breast cancer survivor and their spousal caregiver[J]. J Nepal Health Res Counc, 2024,22(3):502-508.
[28] PHILIPP R, WALBAUM C, KOCH U, et al. Existential distress in advanced cancer: A cohort study[J]. Gen Hosp Psychiatry, 2025,94:184-191.
[29] CHEN Y, CHEN G, ZHENG J, et al. Development and psychometric testing of the existential distress scale for palliative care cancer patients[J]. Psychooncology, 2024,33(11):e70016.
[30] WILLIAMS C. Psychosocial distress and distress screening in multidisciplinary head and neck cancer treatment[J]. Otolaryngol Clin North Am, 2017,50(4):807-823.
[31] 王卫宁, 马凤艳, 刘燕. 自我效能在肺癌患者社会支持与心理痛苦间的中介效应[J]. 中国肿瘤临床与康复, 2024,31(4):249-256.
[32] RADES D, DELIKANLI C, YU N Y, et al. Development of distress during a radiotherapy course for head-and-neck cancer[J]. Anticancer Res, 2023,43(9):4149-4153.
[33] XU G, ZHENG J, LIN X, et al. Existential distress and associated factors in advanced cancer patients: A cross-sectional study[J]. Palliat Support Care, 2024,22(5):1094-1101.
[34] SAEZ-CLARKE E, WALSH E A, LOVAN P, et al. Distress tolerance and perceived cancer-related cognitive impairment in nonmetastatic breast cancer[J]. Health Psychol, 2025,44(2):166-170.
[35] SELAND M, SKREDE K, LINDEMANN K, et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer[J]. Acta Obstet Gynecol Scand, 2022,101(3):313-322.
PDF(896 KB)
